Prediabetes in young adults: could early detection prevent diabetes?
NCT ID NCT07259954
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will observe 120 young adults with prediabetes to understand how different types of prediabetes relate to metabolic syndrome, a cluster of conditions that raise the risk for heart disease and diabetes. Researchers will classify participants based on blood sugar levels and check for insulin resistance, abnormal cholesterol, and fatty liver. The goal is to identify factors that might help predict who is most likely to develop full-blown diabetes, so that early prevention can be targeted.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify which young adults with prediabetes are at highest risk for metabolic syndrome and diabetes, guiding earlier prevention efforts.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't test any intervention. It may not lead to direct changes in care, and results may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Feb 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will consist of young adults aged 18-40 years attending outpatient clinics at Assiut University Hospital. Participants will be screened for prediabetes using fasting plasma glucose, 2-hour postprandial glucose, and HbA1c tests. Only individuals diagnosed with prediabetes according to ADA criteria (impaired fasting glucose, impaired glucose tolerance, or elevated HbA1c) will be included
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * adults diagnosed with prediabetes Exclusion Criteria: * previous diagnosis of overt diabetes * other causes of CKD (e.g. urinary tract infection) * other causes of liver disease (e.g. HBV infection), * use of medications that alter glucose or lipid metabolism (e.g. corticosteroids), * current pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prediabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Very-Low-Carb diet reverse prediabetes? trial puts it to the test
- Heartbeat test aims to catch hidden nerve damage in diabetes
- Can four minutes of hard exercise match a longer workout for blood sugar?
- Can a Plant-Based diet program help patients lose weight and improve heart health?
- Can a health coach in your patient portal help you lose weight?
- Glucose sensor may flag diabetes risk in cystic fibrosis